
    
      PRIMARY OBJECTIVES:

      I. To prospectively observe patients who receive radiation +/- chemotherapy immediately after
      lymph node dissection to confirm the safety of this procedure.

      OUTLINE:

      Patients receive standard therapy including sentinel lymph node dissection. Patients are then
      observed to collect information about treatment and outcomes every 2 months for 2 years.
    
  